{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:51:25Z","timestamp":1781891485900,"version":"3.54.5"},"reference-count":151,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.retram.2026.103573","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:28:45Z","timestamp":1771950525000},"page":"103573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD28 pathway blockade to transplant tolerance: Expanding the landscape of immune regulation"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-7893","authenticated-orcid":false,"given":"Mohammad Afzal","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.retram.2026.103573_bib0001","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ajt.2025.06.030","article-title":"Sensitization in Transplantation Assessment of Risk 2025 innate working group: the potential role of innate allorecognition in kidney allograft damage","volume":"25","author":"Thaunat","year":"2025","journal-title":"Am J Transpl"},{"issue":"10","key":"10.1016\/j.retram.2026.103573_bib0002","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41581-022-00600-0","article-title":"Activation and regulation of alloreactive T cell immunity in solid organ transplantation","volume":"18","author":"Duneton","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"1010","key":"10.1016\/j.retram.2026.103573_bib0003","article-title":"C5a Blockade increases regulatory T cell numbers and protects against microvascular loss and epithelial damage in mouse airway allografts","volume":"9","author":"Khan","year":"2018","journal-title":"Front Immunol"},{"issue":"15","key":"10.1016\/j.retram.2026.103573_bib0004","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1073\/pnas.1217991110","article-title":"Targeting complement component 5a promotes vascular integrity and limits airway remodeling","volume":"110","author":"Khan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1034\/j.1600-6143.2003.00036.x","article-title":"Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction","volume":"3","author":"Csencsits","year":"2003","journal-title":"Am J Transpl"},{"issue":"11","key":"10.1016\/j.retram.2026.103573_bib0006","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCRESAHA.111.250167","article-title":"CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants","volume":"109","author":"Khan","year":"2011","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0007","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41392-025-02371-z","article-title":"Immunosenescence: signaling pathways, diseases and therapeutic targets","volume":"10","author":"Fu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12967-020-02305-z","article-title":"Hypoxia-induced complement dysregulation is associated with microvascular impairments in mouse tracheal transplants","volume":"18","author":"Khan","year":"2020","journal-title":"J Transl Med"},{"issue":"Suppl 4","key":"10.1016\/j.retram.2026.103573_bib0009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ajt.15844","article-title":"Mechanisms of organ transplant injury mediated by B cells and antibodies: implications for antibody-mediated rejection","volume":"20","author":"Chong","year":"2020","journal-title":"Am J Transpl"},{"issue":"19","key":"10.1016\/j.retram.2026.103573_bib0010","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188346","article-title":"Emerging roles for complement in lung transplantation","volume":"135","author":"Kulkarni","year":"2025","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0011","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/JLB.5RU0718-288R","article-title":"Complement factor and T-cell interactions during alloimmune inflammation in transplantation","volume":"105","author":"Khan","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.retram.2026.103573_bib0012","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12967-015-0565-2","article-title":"Complement mediators: key regulators of airway tissue remodeling in asthma","volume":"13","author":"Khan","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.retram.2026.103573_bib0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4614-4118-2_16","article-title":"Complement-mediated microvascular injury leads to chronic rejection","volume":"734","author":"Khan","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.retram.2026.103573_bib0014","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1172\/JCI46192","article-title":"Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection","volume":"121","author":"Jiang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2026.103573_bib0015","article-title":"Bronchial anastomotic complications as a microvascular disruption in a mouse model of airway transplantation","volume":"16 - 2025","author":"Khan","year":"2025","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.retram.2026.103573_bib0016","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/TP.0000000000002571","article-title":"Preservation of microvascular integrity in murine orthotopic tracheal allografts by Clopidogrel","volume":"103","author":"Heim","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2026.103573_bib0017","doi-asserted-by":"crossref","unstructured":"Kazmi S., Khan M.A., Shamma T., Altuhami A., Ahmed H.A., Mohammed Assiri A., et al. Targeting interleukin-10 restores graft microvascular supply and airway epithelium in rejecting allografts. 2022;23(3):1269.","DOI":"10.3390\/ijms23031269"},{"key":"10.1016\/j.retram.2026.103573_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2025.08.021","article-title":"Antibody-independent microvascular inflammation impacts long-term risk in heart transplantation","author":"Huang","year":"2025","journal-title":"J Card Fail"},{"issue":"7","key":"10.1016\/j.retram.2026.103573_bib0019","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ajt.2025.03.031","article-title":"Microvascular inflammation in kidney allografts: new directions for patient management","volume":"25","author":"Bohmig","year":"2025","journal-title":"Am J Transpl"},{"key":"10.1016\/j.retram.2026.103573_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.14032","article-title":"Shedding light on microvascular inflammation: understanding outcomes, but what sparks the flame?","volume":"37","author":"Benning","year":"2024","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.retram.2026.103573_bib0021","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/TP.0000000000002242","article-title":"Contemporary strategies and barriers to transplantation tolerance","volume":"102","author":"Ezekian","year":"2018","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0022","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1172\/JCI67226","article-title":"Harnessing FOXP3+ regulatory T cells for transplantation tolerance","volume":"124","author":"Waldmann","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2026.103573_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1235889","article-title":"Monitoring regulatory T cells as a prognostic marker in lung transplantation","volume":"14","author":"Khan","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0024","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12967-020-02632-1","article-title":"Regulatory T cells mediated immunomodulation during asthma: a therapeutic standpoint","volume":"18","author":"Khan","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.retram.2026.103573_bib0025","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2016.00050","article-title":"T regulatory cell mediated immunotherapy for solid organ transplantation: a clinical perspective","volume":"22","author":"Khan","year":"2016","journal-title":"Mol Med"},{"key":"10.1016\/j.retram.2026.103573_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108621","article-title":"Therapeutic nexus of T cell immunometabolism in improving transplantation immunotherapy","volume":"106","author":"Kazmi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.retram.2026.103573_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1328193","article-title":"Mechanisms underlying immunosuppression by regulatory cells","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.retram.2026.103573_bib0028","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/TP.0000000000004798","article-title":"Regulatory B cells in solid organ transplantation: from Immune monitoring to immunotherapy","volume":"108","author":"Elias","year":"2024","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0029","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/imr.12933","article-title":"Regulatory B cells: TIM-1, transplant tolerance, and rejection","volume":"299","author":"Cherukuri","year":"2021","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.immuni.2024.01.013","article-title":"The B7:CD28 family and friends: unraveling coinhibitory interactions","volume":"57","author":"Burke","year":"2024","journal-title":"Immunity"},{"issue":"5 Pt 1","key":"10.1016\/j.retram.2026.103573_bib0031","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1600-6143.2006.01259.x","article-title":"A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression","volume":"6","author":"Larsen","year":"2006","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0032","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.retram.2026.103573_bib0033","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1111\/j.1600-6143.2012.04164.x","article-title":"Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody","volume":"12","author":"Poirier","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.retram.2026.103573_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1630940","article-title":"Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques","volume":"16","author":"Kang","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cei\/uxad048","article-title":"Development and function of FOXP3+ regulators of immune responses","volume":"213","author":"Golzari-Sorkheh","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.retram.2026.103573_bib0036","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.retram.2026.103573_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2023.1217065","article-title":"Tregs in transplantation tolerance: role and therapeutic potential","volume":"2","author":"Cassano","year":"2023","journal-title":"Front Transpl"},{"issue":"7","key":"10.1016\/j.retram.2026.103573_bib0038","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1172\/JCI90598","article-title":"Transplant trials with Tregs: perils and promises","volume":"127","author":"Tang","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2026.103573_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.719954","article-title":"Regulatory T-cell therapy in liver transplantation and chronic liver disease","volume":"12","author":"Hann","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.retram.2026.103573_bib0040","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1111\/ajt.16724","article-title":"In vivo Treg expansion under costimulation blockade targets early rejection and improves long-term outcome","volume":"21","author":"Schwarz","year":"2021","journal-title":"Am J Transpl"},{"issue":"22","key":"10.1016\/j.retram.2026.103573_bib0041","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa051907","article-title":"Messenger RNA for FOXP3 in the urine of renal-allograft recipients","volume":"353","author":"Muthukumar","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.retram.2026.103573_bib0042","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/j.1600-6143.2011.03633.x","article-title":"Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome","volume":"11","author":"Bestard","year":"2011","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0043","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000203166.44968.86","article-title":"Contrasting CD25hiCD4+T cells\/FOXP3 patterns in chronic rejection and operational drug-free tolerance","volume":"81","author":"Louis","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2026.103573_bib0044","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2017.00218","article-title":"The induction and maintenance of transplant tolerance engages both regulatory and anergic CD4(+) T cells","volume":"8","author":"Besancon","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.retram.2026.103573_bib0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169119","article-title":"Intragraft memory-like CD127hiCD4+Foxp3+ tregs maintain transplant tolerance","volume":"9","author":"Zhao","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.retram.2026.103573_bib0046","doi-asserted-by":"crossref","first-page":"m3734","DOI":"10.1136\/bmj.m3734","article-title":"Regulatory T cells for minimising immune suppression in kidney transplantation: phase I\/IIa clinical trial","volume":"371","author":"Roemhild","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0047","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.ajt.2023.06.012","article-title":"Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial","volume":"23","author":"Guinan","year":"2023","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0048","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.retram.2026.103573_bib0049","article-title":"Regulatory T cell therapy in autoimmune liver disease and transplantation","volume":"7","author":"Fleming","year":"2025","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0051","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/tri.14163","article-title":"Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation","volume":"34","author":"Bergstrom","year":"2021","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0052","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.healun.2013.11.004","article-title":"T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model","volume":"33","author":"Pilat","year":"2014","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0053","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-024-47575-z","article-title":"Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease","volume":"15","author":"Dittmar","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.retram.2026.103573_bib0054","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2016.11.011","article-title":"FOXP3+ regulatory T cell ameliorates microvasculature in the rejection of mouse orthotopic tracheal transplants","volume":"174","author":"Khan","year":"2017","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0055","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1097\/MIB.0b013e3182a85709","article-title":"Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients","volume":"19","author":"Ueno","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0056","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) FoxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.retram.2026.103573_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7828735","article-title":"The plasticity of CD4(+)CD25(+)FOXP3(+)CD127(low) T cells in patients with metastatic renal cell carcinoma in the course of interferon-alpha immunotherapy","volume":"2018","author":"Sayapina","year":"2018","journal-title":"J Oncol"},{"key":"10.1016\/j.retram.2026.103573_bib0058","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol"},{"issue":"24","key":"10.1016\/j.retram.2026.103573_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245877","article-title":"Promises and pitfalls of next-generation treg adoptive immunotherapy","volume":"15","author":"Christofi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cei\/uxac118","article-title":"The potential for Treg-enhancing therapies in transplantation","volume":"211","author":"Steiner","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0061","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cei\/uxad051","article-title":"Regulatory T-cell dysfunction and its implication for cell therapy","volume":"213","author":"Valentini","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.retram.2026.103573_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10297","article-title":"Modeling the potential of treg-based therapies for transplant rejection: effect of dose, timing, and accumulation site","volume":"35","author":"Lapp","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.retram.2026.103573_bib0063","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fimmu.2011.00030","article-title":"B7\/CD28 in central tolerance: costimulation promotes maturation of regulatory T cell precursors and prevents their clonal deletion","volume":"2","author":"Hinterberger","year":"2011","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0064","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.4049\/jimmunol.181.4.2285","article-title":"CD28 controls differentiation of regulatory T cells from naive CD4 T cells","volume":"181","author":"Guo","year":"2008","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.retram.2026.103573_bib0065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 Costimulation: from mechanism to therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0066","article-title":"Belatacept as salvage maintenance immunosuppression in a liver transplant recipient","volume":"5","author":"Lang","year":"2020","journal-title":"Transplant Rep"},{"issue":"11","key":"10.1016\/j.retram.2026.103573_bib0067","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1097\/TXD.0000000000001229","article-title":"Belatacept conversion in kidney after liver transplantation","volume":"7","author":"Cristea","year":"2021","journal-title":"Transpl Direct"},{"issue":"7","key":"10.1016\/j.retram.2026.103573_bib0068","article-title":"Belatacept treatment of recurrent late-onset T cell\u2013mediated rejection\/antibody-mediated rejection with de novo donor-specific antibodies in a liver transplant patient","volume":"8","author":"Klintmalm","year":"2022","journal-title":"Transplant Direct"},{"issue":"8","key":"10.1016\/j.retram.2026.103573_bib0069","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/ajt.12810","article-title":"Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study","volume":"14","author":"Klintmalm","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.retram.2026.103573_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106147","article-title":"CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants","author":"Khan","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.retram.2026.103573_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2484825","article-title":"CTLA4Ig Improves murine iTreg induction via TGFbeta and suppressor function In vitro","volume":"2018","author":"Pilat","year":"2018","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.retram.2026.103573_bib0072","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92033","article-title":"CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients","volume":"2","author":"Khiew","year":"2017","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.retram.2026.103573_bib0073","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/TP.0000000000002740","article-title":"Selective costimulation blockade with antagonist anti-CD28 therapeutics in transplantation","volume":"103","author":"Vanhove","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2026.103573_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.926648","article-title":"Targeting inflammation and immune activation to improve CTLA4-ig-based modulation of transplant rejection","volume":"13","author":"Iglesias","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0076","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transpl"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0077","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0b013e3181ff87cd","article-title":"Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies","volume":"90","author":"Larsen","year":"2010","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0078","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/ajt.16842","article-title":"Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade","volume":"22","author":"Shimozawa","year":"2022","journal-title":"Am J Transpl"},{"issue":"17","key":"10.1016\/j.retram.2026.103573_bib0079","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.retram.2026.103573_bib0080","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jaci.2024.08.020","article-title":"Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study","volume":"154","author":"Tsilifis","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0081","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.intimp.2013.02.007","article-title":"CTLA4-Ig immunosuppressive activity at the level of dendritic cell\/T cell crosstalk","volume":"15","author":"Mayer","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.retram.2026.103573_bib0082","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211046556","article-title":"Benefit of belatacept in cord blood-derived regulatory T cell-mediated suppression of alloimmune response","volume":"30","author":"He","year":"2021","journal-title":"Cell Transpl"},{"issue":"10237","key":"10.1016\/j.retram.2026.103573_bib0083","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2026.103573_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2025.12.283","article-title":"Dual targeting of B cell compartments using belatacept and daratumumab in highly sensitized kidney transplant candidates: A mechanistic proof-of-concept desensitization trial","author":"Malvezzi","year":"2026","journal-title":"Am J Transpl"},{"key":"10.1016\/j.retram.2026.103573_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2025.100277","article-title":"Belatacept-based immunosuppression in heart transplant recipients: A single center experience","volume":"9","author":"Magua","year":"2025","journal-title":"JHLT Open"},{"issue":"10","key":"10.1016\/j.retram.2026.103573_bib0086","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.transproceed.2025.10.023","article-title":"Immunosuppression minimization in belatacept-treated kidney transplant recipients guided by combined cell-free DNA and blood gene expression monitoring","volume":"57","author":"Vanhove","year":"2025","journal-title":"Transpl Proc"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0087","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/2326-6066.CIR-13-0020","article-title":"Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy","volume":"1","author":"Ng Tang","year":"2013","journal-title":"Cancer Immunol Res"},{"issue":"17","key":"10.1016\/j.retram.2026.103573_bib0088","doi-asserted-by":"crossref","first-page":"17ra0","DOI":"10.1126\/scitranslmed.3000116","article-title":"Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation","volume":"2","author":"Poirier","year":"2010","journal-title":"Sci Transl Med"},{"issue":"19","key":"10.1016\/j.retram.2026.103573_bib0089","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89381","article-title":"Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses","volume":"2","author":"Zaitsu","year":"2017","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0090","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.1601538","article-title":"First-in-Human study in healthy subjects with FR104, a Pegylated monoclonal antibody fragment antagonist of CD28","volume":"197","author":"Poirier","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0091","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ajt.12964","article-title":"FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft","volume":"15","author":"Poirier","year":"2015","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0092","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/TP.0000000000002044","article-title":"Selective CD28 inhibition modulates alloimmunity and cardiac allograft vasculopathy in anti-CD154-treated monkeys","volume":"102","author":"Zhang","year":"2018","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2024.101407","article-title":"Rethinking immune check point inhibitors use in liver transplantation: implications and resistance","volume":"19","author":"Ortiz","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0094","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40472-019-00260-3","article-title":"Belatacept and CD28 costimulation blockade: preventing and reducing alloantibodies over the long term","volume":"6","author":"Parsons","year":"2019","journal-title":"Curr Transpl Rep"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0095","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ajt.2023.01.007","article-title":"Localized cytotoxic T cell-associated antigen 4 and antioxidant islet encapsulation alters macrophage signaling and induces regulatory and anergic T cells to enhance allograft survival","volume":"23","author":"Barra","year":"2023","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0096","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcph.791","article-title":"Pharmacokinetic, pharmacodynamic, and safety profile of a novel anti-CD28 domain antibody antagonist in healthy subjects","volume":"57","author":"Shi","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"21","key":"10.1016\/j.retram.2026.103573_bib0097","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016168118","article-title":"Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities","volume":"118","author":"Yin","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0098","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12943-025-02476-7","article-title":"Nanoparticle-based strategy in CAR-T cell immunotherapy: challenges, implications, and perspectives","volume":"24","author":"Shang","year":"2025","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0099","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4049\/jimmunol.1502039","article-title":"Regulatory T cell-dependent and -independent mechanisms of Immune suppression by CD28\/B7 and CD40\/CD40L costimulation blockade","volume":"197","author":"Vogel","year":"2016","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.retram.2026.103573_bib0100","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood-2004-10-3869","article-title":"Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)","volume":"105","author":"Taylor","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0101","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.4049\/jimmunol.152.12.5643","article-title":"Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction","volume":"152","author":"Klaus","year":"1994","journal-title":"J Immunol"},{"issue":"43","key":"10.1016\/j.retram.2026.103573_bib0102","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0103","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOT.0000000000000193","article-title":"The molecular phenotypes of rejection in kidney transplant biopsies","volume":"20","author":"Halloran","year":"2015","journal-title":"Curr Opin Organ Transpl"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nri2474","article-title":"Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?","volume":"9","author":"Huehn","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0105","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0106","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.4049\/jimmunol.1090105","article-title":"Comment on \"expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"185","author":"Verhagen","year":"2010","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.retram.2026.103573_bib0107","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0108","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.retram.2026.103573_bib0109","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.retram.2026.103573_bib0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ni1504","article-title":"Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10","volume":"8","author":"Maynard","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.retram.2026.103573_bib0111","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.15555","article-title":"%dd-cfDNA: the new frontier for heart\/lung transplant surveillance?","volume":"38","author":"Agbor-Enoh","year":"2025","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0112","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MOT.0000000000000979","article-title":"Cell-free DNA in lung transplantation: research tool or clinical workhorse?","volume":"27","author":"Keller","year":"2022","journal-title":"Curr Opin Organ Transpl"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000509796","article-title":"Cell-free DNA testing: what is the reason why high-risk women choose it?","volume":"48","author":"Benitez-Quintanilla","year":"2021","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0114","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13665-022-00292-8","article-title":"Why cell-free DNA can Be a \"game changer\" for lung allograft monitoring for rejection and infection","volume":"11","author":"Rosenheck","year":"2022","journal-title":"Curr Pulmonol Rep"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0115","doi-asserted-by":"crossref","DOI":"10.3390\/bios14040189","article-title":"Single-cell RNA sequencing in organ and cell transplantation","volume":"14","author":"Abedini-Nassab","year":"2024","journal-title":"Biosensors"},{"issue":"8","key":"10.1016\/j.retram.2026.103573_bib0116","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ni.3485","article-title":"Mass cytometry: blessed with the curse of dimensionality","volume":"17","author":"Newell","year":"2016","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.retram.2026.103573_bib0117","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex digital spatial profiling of proteins and RNA in fixed tissue","volume":"38","author":"Merritt","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.retram.2026.103573_bib0118","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.transproceed.2023.07.021","article-title":"Machine learning model to predict graft rejection after kidney transplantation","volume":"55","author":"Minato","year":"2023","journal-title":"Transpl Proc"},{"issue":"11","key":"10.1016\/j.retram.2026.103573_bib0119","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0120","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/ajt.16395","article-title":"Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients","volume":"21","author":"Harden","year":"2021","journal-title":"Am J Transpl"},{"key":"10.1016\/j.retram.2026.103573_bib0121","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T cell-based cell therapy in living donor liver transplantation","author":"Todo","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.retram.2026.103573_bib0122","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10875-023-01462-2","article-title":"CTLA4-Ig effectively controls clinical deterioration and immune condition in a murine model of Foxp3 deficiency","volume":"43","author":"Gerbaux","year":"2023","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0123","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/ajt.12936","article-title":"Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates","volume":"14","author":"Yamada","year":"2014","journal-title":"Am J Transpl"},{"issue":"7","key":"10.1016\/j.retram.2026.103573_bib0124","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/ajt.15306","article-title":"IL-2 therapy preferentially expands adoptively transferred donor-specific tregs improving skin allograft survival","volume":"19","author":"Ratnasothy","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.retram.2026.103573_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1257652","article-title":"Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo","volume":"14","author":"Ma","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0126","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1038\/s41467-023-41483-4","article-title":"Author correction: costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43556-025-00401-4","article-title":"CAR-engineered cell therapies: current understandings and future perspectives","volume":"7","author":"Bayat","year":"2026","journal-title":"Mol Biomed"},{"issue":"5","key":"10.1016\/j.retram.2026.103573_bib0128","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/ajt.14217","article-title":"A tale of two pathways: renewing the promise of Anti-CD40L Blockade","volume":"17","author":"Thomson","year":"2017","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0129","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.kint.2018.10.028","article-title":"Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives","volume":"95","author":"Leibler","year":"2019","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.retram.2026.103573_bib0130","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.ekir.2023.08.037","article-title":"Costimulatory blockade and solid organ transplantation: the past, present, and future","volume":"8","author":"Kitchens","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40472-025-00479-3","article-title":"Novel drug strategies in kidney transplantation","volume":"12","author":"El Chediak","year":"2025","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.retram.2026.103573_bib0132","first-page":"163","article-title":"Strategies to improve novel drug development in kidney transplantation through the clinical trials process","volume":"31","author":"Jordan","year":"2015","journal-title":"Clin Transpl"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0133","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41392-025-02525-z","article-title":"Correction: evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.retram.2026.103573_bib0134","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.915963","article-title":"Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human naive CD4(+) T cells","volume":"13","author":"Gigliotti","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.retram.2026.103573_bib0135","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13102325","article-title":"Donor-derived cell-free DNA in allograft transplantation: exaggerated hope or cautious reality?","volume":"13","author":"Fernandez-Gonzalez","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0136","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12967-024-05964-4","article-title":"Advancements in noninvasive techniques for transplant rejection: from biomarker detection to molecular imaging","volume":"23","author":"Song","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.retram.2026.103573_bib0137","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1490472","article-title":"Current and emerging tools for simultaneous assessment of infection and rejection risk in transplantation","volume":"15","author":"Tharmaraj","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.retram.2026.103573_bib0138","article-title":"Non-invasive biomarkers for early diagnosis of kidney allograft dysfunction: current and future applications in the era of precision medicine","volume":"61","author":"Lazarou","year":"2025","journal-title":"Medicines"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0139","doi-asserted-by":"crossref","first-page":"S725","DOI":"10.1016\/j.healun.2025.02.1560","article-title":"Targeting TSG-6 mediated immunomodulation promotes anastomotic healing in mouse airway allografts","volume":"44","author":"Khan","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.retram.2026.103573_bib0140","article-title":"TSG-6 expression distinguishes rejected and non-rejected human lung transplants: a retrospective study","volume":"16 - 2025","author":"Khan","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.retram.2026.103573_bib0141","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.746889","article-title":"Utilization of treg cells in solid organ transplantation","volume":"13","author":"Juneja","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.retram.2026.103573_bib0142","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173107","article-title":"A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models","volume":"134","author":"Efe","year":"2024","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.retram.2026.103573_bib0143","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/TP.0000000000004316","article-title":"Do treg speed up with CARs? Chimeric antigen receptor treg engineered to induce transplant tolerance","volume":"107","author":"Kaljanac","year":"2023","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0144","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3324\/haematol.2019.231183","article-title":"CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells","volume":"106","author":"Guercio","year":"2021","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.retram.2026.103573_bib0145","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/1078-0432.CCR-18-2559","article-title":"Combined CD28 and 4-1BB costimulation potentiates affinity-tuned chimeric antigen receptor-engineered T cells","volume":"25","author":"Drent","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.retram.2026.103573_bib0146","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/ajt.15316","article-title":"Single cell immune profiling in transplantation research","volume":"19","author":"Higdon","year":"2019","journal-title":"Am J Transpl"},{"issue":"6","key":"10.1016\/j.retram.2026.103573_bib0147","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.kint.2023.02.018","article-title":"Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis","volume":"103","author":"McDaniels","year":"2023","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.retram.2026.103573_bib0148","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.celrep.2019.06.049","article-title":"Comprehensive immune monitoring of clinical trials to advance Human immunotherapy","volume":"28","author":"Hartmann","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.retram.2026.103573_bib0149","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1060576","article-title":"Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-ig dosing regimen","volume":"13","author":"Unger","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/TP.0b013e318298dd65","article-title":"Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection","volume":"96","author":"Banham","year":"2013","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.retram.2026.103573_bib0151","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ajt.13613","article-title":"CD57(+) CD4 T cells underlie belatacept-resistant allograft rejection","volume":"16","author":"Espinosa","year":"2016","journal-title":"Am J Transpl"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:57:00Z","timestamp":1781888220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318626000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":151,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2452318626000103"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2026.103573","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD28 pathway blockade to transplant tolerance: Expanding the landscape of immune regulation","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2026.103573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103573"}}